| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 1,087,000 | 1,085,000 | 1,100,000 | 1,067,000 | | Cost of Revenue | 154,000 | 274,000 | 282,000 | 88,000 | | | Gross Profit | 933,000 | 811,000 | 818,000 | 979,000 | | | Operating Expenses | | Research Development | 123,000 | 133,000 | 38,000 | 174,000 | | Selling General and Administrative | 431,000 | 504,000 | 427,000 | 492,000 | | Non Recurring | 4,000 | 72,000 | 35,000 | 2,000 | | Others | 67,000 | (48,000) | 69,000 | 67,000 | | | | Total Operating Expenses | 625,000 | 661,000 | 569,000 | 735,000 | | | | Operating Income or Loss | 308,000 | 150,000 | 249,000 | 244,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 308,000 | 150,000 | 249,000 | 244,000 | | Interest Expense | 4,000 | 9,000 | 10,000 | 13,000 | | Income Before Tax | 304,000 | 141,000 | 239,000 | 231,000 | | Income Tax Expense | 104,000 | 70,000 | 76,000 | 94,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 200,000 | 71,000 | 163,000 | 137,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 200,000 | 71,000 | 163,000 | 137,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $200,000 | $71,000 | $163,000 | $137,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
